SKIN1004 Madagascar Centella Tone Brightening Capsule Ampoule: centella and brightening for post-inflammatory marks

Post-inflammatory hyperpigmentation: the aftermath of breakouts

Post-inflammatory hyperpigmentation (PIH) is the flat, discoloured mark left after an acne lesion, skin irritation or wound heals. Unlike active acne (which is an inflammatory process), PIH is a consequence of the skin's melanin response to that inflammation — melanocytes overproducing melanin as part of the healing response, depositing excess pigment in the healing tissue. PIH is more common and more persistent in darker skin tones, where melanocytes are more reactive to inflammatory stimuli. For skin with acne history, clearing the acne is only the first challenge — fading the resulting PIH marks is typically a longer process requiring specific actives.

How the SKIN1004 ampoule targets PIH specifically

SKIN1004 Madagascar Centella Tone Brightening Capsule Ampoule 100ml addresses PIH through a two-component strategy: centella asiatica reduces the inflammatory signal that drives melanin overproduction (working at the cause), while the brightening actives (vitamin C derivatives, niacinamide) inhibit tyrosinase and disperse existing melanin deposits (working at the pigment). This dual-mechanism approach is more effective than brightening actives alone — purely brightening products can fade existing PIH marks but do not prevent new ones from forming if the inflammatory trigger is still active. SKIN1004's centella-anchored formulation addresses the underlying inflammation while simultaneously treating the pigment consequence.

The "capsule" format: encapsulated brightening actives

The "capsule" descriptor in the ampoule name refers to microencapsulated brightening actives that are released on skin contact. Encapsulation improves stability of light- and air-sensitive actives like vitamin C derivatives, extending their active lifespan in the formula. The encapsulated particles also provide a visual texture element — tiny spheres visible in the ampoule that burst on application. The release of encapsulated actives on skin contact ensures the brightening compounds reach the skin in their active form rather than partially degraded, as can occur in conventional open formulas.

How to apply the SKIN1004 brightening ampoule

SKIN1004 Madagascar Centella Tone Brightening Capsule Ampoule is applied in the evening routine after cleansing and toner, before the SKIN1004 Soothing Cream. Dispense 2-3 drops onto the palm, press palms together to break the capsules (gentle pressing, not rubbing), then apply to the face by pressing the palms against the skin. The capsule-breaking step activates the encapsulated actives before skin contact. Allow sixty seconds for the ampoule to absorb before applying the Soothing Cream over it. On mornings with outdoor exposure, follow the morning routine with a SKIN1004 centella SPF — UV protection is critical when using brightening actives, as UV exposure re-triggers the melanin production that the actives are working to suppress.

Realistic expectations: PIH fading timeline

Post-inflammatory hyperpigmentation responds to brightening treatment but on a slow timeline governed by skin cell turnover. Superficial PIH (marks in the epidermis) can fade measurably within four to eight weeks of consistent brightening ampoule use alongside daily SPF. Deeper PIH (marks extending into the upper dermis) may take six to twelve months of consistent treatment. The SKIN1004 ampoule cannot accelerate cell turnover beyond its natural rate — but it reduces the melanin load in each turnover cycle, so that each new cell generated contains less pigment than the cell it replaces. Consistent use produces gradual, progressive fading rather than sudden improvement.